SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Germanecki6/25/2012 11:01:47 AM
of 4974
 
MorphoSys AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

MorphoSys AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. On June 18, 2012, BVF Investments, L.L.C., Chicago, IL, USA, has informed us in accordance with §§ 21 para. 1, 22 para. 1 of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG) regarding the shareholding in MorphoSys AG, Martinsried/Planegg, Germany (ISIN: DE0006632003, German Security Code: 663200), about the following:

1. On May 31, 2012 the voting interest of Mr. Mark N. Lampert, U.S.A., in MorphoSys AG exceeded the thresholds of 3% and 5% of the voting rights and amounts to 6.01% (1,391,610 voting rights) on that day.

Of these voting rights 5.83% (1,349,610 voting rights) is to be attributed to Mr. Mark N. Lampert pursuant sec. 22 para. 1 sent. 1 no. 6, sent. 2 WpHG inter alia from BVF Investments, L.L.C., Chicago, IL, U.S.A., which is a shareholder holding 3% or more.

Further 0.18% (42,000 voting rights) is to be attributed to Mr. Mark N. Lampert pursuant sec. 22 para. 1 sent. 1 no. 1 WpHG from BVF Inc., Chicago, IL, U.S.A., and BVF Partners L.P., Chicago, IL, U.S.A., which are controlled entities holding 3% or more.

2. On May 31, 2012 the voting interest of BVF Inc., Chicago, IL, U.S.A., in MorphoSys AG exceeded the thresholds of 3% and 5% of the voting rights and amounts to 6.01% (1,391,610 voting rights) on that day.

Of these voting rights 5.83 % (1,349,610 voting rights) is to be attributed to BVF Inc., Chicago, IL, U.S.A., pursuant sec. 22 para. 1 sent. 1 no. 6, sent. 2 WpHG inter alia from BVF Investments, L.L.C., Chicago, IL, U.S.A., which is a shareholder holding 3% or more.

Further 0.18% (42,000 voting rights) is to be attributed to BVF Inc., Chicago, IL, U.S.A., pursuant sec. 22 para. 1 sent. 1 no. 1 WpHG from BVF Partners L.P., Chicago, IL, U.S.A., which is a controlled entity holding 3% or more.

3. On May 31, 2012 the voting interest of BVF Partners L.P., Chicago, IL, U.S.A., in MorphoSys AG exceeded the thresholds of 3% and 5% of the voting rights and amounts to 6.01% (1,391,610 voting rights) on that day.

Of these voting rights 5.83% (1,349,610 voting rights) is to be attributed to BVF Partners L.P., Chicago, IL, U.S.A., pursuant sec. 22 para. 1 sent. 1 no. 6 WpHG inter alia from BVF Investments, L.L.C., Chicago, IL, U.S.A., which is a shareholder holding 3% or more.

Further 0.18% (42,000 voting rights) is to be attributed to BVF Partners L.P., Chicago, IL, U.S.A., pursuant sec. 22 para. 1 sent. 1 no. 1 WpHG.

4. On May 31, 2012 the voting interest of BVF Investments, L.L.C., Chicago, IL, U.S.A., in MorphoSys AG exceeded the thresholds of 3% and 5% of the voting rights and amounts to 5.80% (1,343,610 voting rights) on that day.

Martinsried, June 25, 2012

The Management Board

Contact:

MorphoSys AG

Dr. Claudia Gutjahr-Löser

Head of Corporate Communications & IR

Tel.: +49 89 899 27 122

investors@morphosys.com







This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext